| 106618-2 | Influenza virus B NS gene in Nasopharynx (qualitative, naa with probe detection) | MICRO |
| 106619-0 | Respiratory syncytial virus N gene in Nasopharynx (qualitative, naa with probe detection) | MICRO |
| 10662-5 | Filaria identified (Blood, concentration) | MICRO |
| 106620-8 | Coagulation factor VIII activity actual/normal in Platelet poor plasma (bovine factor x substrate + chromogenic) | COAG |
| 106622-4 | Cesarean status (qualitative) | OBGYN |
| 106623-2 | Hospice Outcomes and Patient Evaluation (HOPE) Admission v1.0 during assessment period | PANEL.SURVEY.CMS |
| 106624-0 | Hospice Outcomes and Patient Evaluation (HOPE) v1.0 during assessment period | PANEL.SURVEY.CMS |
| 106625-7 | Hospice Outcomes and Patient Evaluation (HOPE) Discharge v1.0 during assessment period | PANEL.SURVEY.CMS |
| 106626-5 | Weight of Thymus gland | PATH |
| 106627-3 | Width palpebral fissure opening in Eye from Fetus | PATH |
| 106628-1 | Parainfluenza virus 1+2+3+4 IgG Ab (immunoassay) | MICRO |
| 106629-9 | Alcohol consumption environment | CLIN.RISK |
| 10663-3 | Filaria identified (Blood, thick film) | MICRO |
| 106630-7 | Alcohol use pattern | CLIN |
| 106631-5 | Site of Service at Admission during assessment period | SURVEY.CMS |
| 106632-3 | Patient ZIP Code during assessment period | SURVEY.CMS |
| 106634-9 | Hemoglobin A1c/Hemoglobin.total (Blood, ifcc protocol) | CHEM |
| 106635-6 | Date the patient or responsible party was first asked about preference regarding the use of CPR during assessment period | SURVEY.CMS |
| 106636-4 | CPR Preference during assessment period | PANEL.SURVEY.CMS |
| 106637-2 | Was the patient or responsible party asked about preference regarding the use of cardiopulmonary resuscitation during assessment period (qualitative) | SURVEY.CMS |
| 106638-0 | Other Life-Sustaining Treatment Preferences during assessment period | PANEL.SURVEY.CMS |
| 106639-8 | Was the patient or responsible party asked about preferences regarding life-sustaining treatments other than CPR during assessment period (qualitative) | SURVEY.CMS |
| 10664-1 | Filaria identified (Blood, thin film) | MICRO |
| 106640-6 | Date the patient or responsible party was first asked about preferences regarding life-sustaining treatments other than CPR during assessment period | SURVEY.CMS |
| 106641-4 | Hospitalization Preference during assessment period | PANEL.SURVEY.CMS |
| 106642-2 | Date the patient and or caregiver was first asked about spiritual or existential concerns during assessment period | SURVEY.CMS |
| 106643-0 | Was the patient and or caregiver asked about spiritual or existential concerns during assessment period (qualitative) | SURVEY.CMS |
| 106644-8 | Spiritual or Existential Concerns during assessment period | PANEL.SURVEY.CMS |
| 106645-5 | Date the patient or responsible party was first asked about preference regarding hospitalization during assessment period | SURVEY.CMS |
| 106646-3 | Was the patient or responsible party asked about preference regarding hospitalization during assessment period (qualitative) | SURVEY.CMS |
| 106647-1 | Principal Diagnosis during assessment period | SURVEY.CMS |
| 106648-9 | Alcoholic drink consumed | CLIN |
| 106649-7 | Comorbidities and Co-existing Conditions during assessment period | SURVEY.CMS |
| 10665-8 | Fungus colony count in Specimen (environmental culture) | MICRO |
| 10666-6 | Fungus identified (Tissue, fontana-masson stain) | MICRO |
| 106663-8 | Pain Screening during assessment period | PANEL.SURVEY.CMS |
| 106664-6 | Death is Imminent during assessment period (qualitative) | SURVEY.CMS |
| 106665-3 | Was the patient screened for pain during assessment period (qualitative) | SURVEY.CMS |
| 106666-1 | Date of first screening for pain during assessment period | SURVEY.CMS |
| 106667-9 | Patient's pain severity during assessment period (qualitative) | SURVEY.CMS |
| 106668-7 | Was a comprehensive pain assessment done during assessment period (qualitative) | SURVEY.CMS |
| 106669-5 | Type of standardized pain tool used during assessment period | SURVEY.CMS |
| 10667-4 | Fungus identified in Specimen (animal inoculation) | MICRO |
| 106670-3 | Pain Active Problem during assessment period (qualitative) | SURVEY.CMS |
| 106671-1 | Comprehensive Pain Assessment during assessment period | PANEL.SURVEY.CMS |
| 106672-9 | Date of comprehensive pain assessment during assessment period | SURVEY.CMS |
| 106673-7 | Comprehensive pain assessment included during assessment period | SURVEY.CMS |
| 106674-5 | Neuropathic Pain during assessment period (qualitative) | SURVEY.CMS |
| 106675-2 | Screening for Shortness of Breath during assessment period | PANEL.SURVEY.CMS |
| 106676-0 | Was the patient screened for shortness of breath during assessment period (qualitative) | SURVEY.CMS |